BMC Cancer (Feb 2007)
A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
Abstract
No abstracts available.
BMC Cancer (Feb 2007)